Oppenheimer Sticks to Their Buy Rating for CME Group (CME)
Rosenblatt Adjusts Price Target on CME Group to $173 From $169, Maintains Sell Rating
Bank of America Securities Reaffirms Their Sell Rating on CME Group (CME)
Analysts' Top Financial Picks: Automatic Data Processing (ADP), CME Group (CME)
Morgan Stanley Adjusts Price Target on CME Group to $210 From $208, Maintains Equalweight Rating
Oppenheimer Adjusts CME Group Price Target to $222 From $221, Maintains Outperform Rating
Rosenblatt Securities Adjusts CME Group Price Target to $169 From $161, Maintains Sell Rating
Barclays Sticks to Its Buy Rating for CME Group (CME)
No Data
No Data